AQR Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-41,739
| Closed | -$812K | – | 2437 |
|
|
2018
Q1 | $812K | Hold |
41,739
| – | – | ﹤0.01% | 1751 |
|
|
2017
Q4 | $695K | Buy |
+41,739
| New | +$765K | ﹤0.01% | 1806 |
|
|
2017
Q2 | – | Sell |
-27,641
| Closed | -$350K | – | 2262 |
|
|
2017
Q1 | $350K | Buy |
27,641
+2,212
| +9% | +$26.7K | ﹤0.01% | 1984 |
|
|
2016
Q4 | $337K | Sell |
25,429
-6,389
| -20% | -$109K | ﹤0.01% | 2029 |
|
|
2016
Q3 | $754K | Buy |
31,818
+19,254
| +153% | +$517K | ﹤0.01% | 1817 |
|
|
2016
Q2 | $362K | Sell |
12,564
-4,317
| -26% | -$141K | ﹤0.01% | 1966 |
|
|
2016
Q1 | $541K | Sell |
16,881
-7,330
| -30% | -$258K | ﹤0.01% | 1808 |
|
|
2015
Q4 | $1.03M | Buy |
24,211
+2,940
| +14% | +$117K | ﹤0.01% | 1553 |
|
|
2015
Q3 | $749K | Sell |
21,271
-28,826
| -58% | -$1.3M | ﹤0.01% | 1574 |
|
|
2015
Q2 | $2.3M | Sell |
50,097
-39,229
| -44% | -$1.86M | ﹤0.01% | 1127 |
|
|
2015
Q1 | $4.19M | Sell |
89,326
-7,163
| -7% | -$285K | 0.01% | 845 |
|
|
2014
Q4 | $3.06M | Sell |
96,489
-27,211
| -22% | -$796K | 0.01% | 1098 |
|
|
2014
Q3 | $2.93M | Sell |
123,700
-16,500
| -12% | -$423K | 0.01% | 1065 |
|
|
2014
Q2 | $4.21M | Buy |
140,200
+27,000
| +24% | +$728K | 0.01% | 959 |
|
|
2014
Q1 | $2.99M | Buy |
113,200
+10,700
| +10% | +$267K | 0.01% | 1091 |
|
|
2013
Q4 | $2.58M | Sell |
102,500
-12,000
| -10% | -$268K | 0.01% | 1204 |
|
|
2013
Q3 | $2.35M | Buy |
114,500
+15,600
| +16% | +$322K | 0.01% | 1187 |
|
|
2013
Q2 | $1.97M | Buy |
+98,900
| New | +$1.76M | 0.01% | 1271 |
|
AQR Capital Management's IPXL Position: Q2 2018 in Review
AQR Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 41,739 shares — an estimated $812K sold.
AQR Capital Management first reported a position in IPXL in Q2 2013 and held it in 18 quarters. The position peaked at $4.21M in Q2 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- AQR Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- AQR Capital Management sold 41,739 Impax Laboratories, Inc. shares in Q2 2018, an estimated $812K.
- AQR Capital Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 18 quarters.
- AQR Capital Management's Impax Laboratories, Inc. position peaked at $4.21M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on AQR Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.